Table of Contents
The Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of February 2013 provides a competitor analysis in the development pipeline of novel recombinant and purified FSH, hCG and LH receptor agonists for treatment of infertility.
Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report provides information on the marketed FSH, hCG and LH preparations and includes a compilation of current active projects in research and development of novel FSH, LH and hCG receptor agonists. In addition, the report lists company-specific R&D pipelines of FSH, LH and hCG products and projects.
Competitor projects are listed in a tabular format providing information on:
Target / Mechanism of Action,
Class of Compound,
R&D Stage and
additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Use this report to: - Identify key market dynamics and the factors impacting the global protein-labeling market and its subsegments. - Gain insight into global protein-labeling market and its market segments, ...
“The protein hydrolysates market is projected to grow at a significant rate” The protein hydrolysates market is projected to grow at a CAGR of 8.1% from 2016, to reach USD 738.2 million by 2022. The ...
“Protein Ingredients Market projected to grow at a CAGR of 6.0%” The protein ingredients market has grown rapidly in the last few years and is projected to reach USD 58.49 billion by 2022 at a CAGR ...